Reframing Prostate Cancer as 'Chronic Disease'

Timothy Daskivich, MD; Matthew J. Resnick, MD


May 22, 2013

In This Article

A Change in Paradigm

Dr. Resnick: Moving forward, we may see that prostate cancer is becoming a chronic disease. In many ways, it's already doing that. In diagnosing someone with low-risk prostate cancer and following them for some time, even if they have treatment in 5 or 10 years, you've optimized their function during the time when they had satisfactory sexual, bowel, and urinary function. There may be a change in paradigm in the way we start to treat these men.

Dr. Daskivich: There is no question that the change is in optimization of quality of life in addition to helping men improve their survival from prostate cancer. It is our challenge as health services researchers to translate this information to patients and better inform them. Use population-based statistics to better inform treatment decisions up front. I think PCOS is a great example of how we can use that data, translate it to patients, and effectuate better treatment decision-making and better outcomes for patients.

Dr. Resnick: I couldn't agree more. I think that the ability to work with some of these data, to develop some ideas, and collaborate moving forward as we start to translate these population data to individual patients is going to be very rewarding. My goal and my hope is that we can improve the way we take care of men with prostate cancer and optimize the benefit-to-harm ratio.

Dr. Daskivich: Matt, thanks so much for joining us. I think this has been a great discussion. Thanks to all of you for joining us on Medscape Urology at the American Urological Association Annual Scientific Meeting.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: